UNICHEMLAB — Unichem Laboratories Balance Sheet
0.000.00%
- IN₹49.56bn
- IN₹50.58bn
- IN₹17.05bn
- 52
- 12
- 90
- 52
Annual balance sheet for Unichem Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6,506 | 3,171 | 3,761 | 1,854 | 1,544 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 6,188 | 5,007 | 6,460 | 7,487 | 8,051 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16,865 | 13,773 | 16,449 | 15,885 | 16,942 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 11,950 | 14,464 | 14,823 | 14,026 | 13,171 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 31,447 | 31,257 | 33,188 | 31,930 | 31,693 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5,667 | 5,058 | 5,521 | 6,396 | 7,079 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 6,134 | 5,689 | 7,004 | 7,577 | 8,069 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 25,314 | 25,568 | 26,184 | 24,353 | 23,624 |
Total Liabilities & Shareholders' Equity | 31,447 | 31,257 | 33,188 | 31,930 | 31,693 |
Total Common Shares Outstanding |